Aptose Biosciences Inc. secured $4.43 million in funding through a registered direct offering for working capital and general corporate use.
Aptose Biosciences Inc. secured $4.43 million in funding through a registered direct offering for working capital and general corporate use.
06/03/24, 9:21 PM
Location
san diegoMoney raised
$4.43 million
Industry
biotechnology
Round Type
seed
Investors
H.C. Wainwright & Co.
Aptose Biosciences Inc. has completed a registered direct offering, raising approximately $4.43 million by selling common shares at $1.15 each, as well as issuing series A and B warrants. The funding is intended for working capital and general corporate use.